Remdesivir Company CEO: It’s ‘Not A Cure, But A Very Significant Treatment’ | TODAY

In the wake of a government-sponsored clinical trial that showed promising results for the experimental drug remdesivir to treat coronavirus, Daniel O’Day, chairman and CEO of Gilead Sciences, talks to TODAY in an NBC News exclusive. He says it’s “not a cure, but a very significant treatment” that can “reduce the time it takes patients to get better,” reducing the strain on health care systems. He promises Gilead will work to make the drug “accessible and affordable,” and says they are looking at ways to use the drug for other patients besides the most severely ill.
» Subscribe to TODAY:
» Watch the latest from TODAY:

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

Connect with TODAY Online!
Visit TODAY's Website:
Find TODAY on Facebook:
Follow TODAY on Twitter:
Follow TODAY on Instagram:
Follow TODAY on Pinterest:

#Remdesivir #Coronavirus #TodayShow

Remdesivir Company CEO: It’s ‘Not A Cure, But A Very Significant Treatment’ | TODAY

Health,Editor's picks,Big News,Coronavirus,Coronavirus - Health Tips,The TODAY Show,Celebrity Interviews,TODAY Show Interview,TODAY show news,coronavirus update,coronavirus us,coronavirus news,quarantine,symptoms,social distancing,virus protection,outbreak,COVID-19,pandemic,coronavirus explained,covid-19 news,covid-19 updates,covid-19 outbreak,corona,Remdesivir Company,Very Significant Treatment,government-sponsored clinical,drug remdesivir,Daniel O’Day,